Arax Advisory Partners’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.62K Buy
472
+60
+15% +$614 ﹤0.01% 2728
2025
Q4
$4.1K Sell
412
-8,077
-95% -$77.1K ﹤0.01% 2956
2025
Q3
$76K Buy
+8,489
New +$78.6K ﹤0.01% 1645
2025
Q1
Sell
-112
Closed -$1.07K 2669
2024
Q4
$1.07K Sell
112
-508
-82% -$5.14K ﹤0.01% 2165
2024
Q3
$6.96K Hold
620
﹤0.01% 1562
2024
Q2
$6.2K Buy
+620
New +$6.3K ﹤0.01% 1493

Other funds holding AHCO

Arax Advisory Partners's AHCO Position: Q1 2026 in Review

Arax Advisory Partners increased its AdaptHealth (AHCO) stake by 15% in Q1 2026, buying an estimated $614 and bringing the position to 472 shares worth $5.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2728.

Arax Advisory Partners first reported a position in AHCO in Q2 2024 and has held it in 6 quarters since. The position peaked at $76K in Q3 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Arax Advisory Partners held 472 shares of AdaptHealth worth $5.62K as of Q1 2026.
  • Arax Advisory Partners bought 60 AdaptHealth shares in Q1 2026, an estimated $614.
  • AdaptHealth made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2728 holding.
  • Arax Advisory Partners first reported a position in AdaptHealth in Q2 2024 and has held it in 6 quarters since.
  • Arax Advisory Partners's AdaptHealth position peaked at $76K in Q3 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.